"Research Institute"

During the past decade, Epic Medical Research conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 3 clinical trials were completed, i.e. on average, 15.8% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 3 clinical trials were completed. i.e. 15.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Epic Medical Research" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Pfizer" with 4 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Exact Sciences Corporation" with 2 trials sponsored and "Axcella Health, Inc" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Epic Medical Research" #1 collaborator was "AbCellera Biologics Inc." with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Molecular Partners AG" with 1 trials as a collaborator, "Shanghai Junshi Bioscience Co., Ltd." with 1 trials as a collaborator and "Vir Biotechnology, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Epic Medical Research" are "COVID-19" (6 trials), "Arthritis, Psoriatic" (3 trials), "Colorectal Cancer" (2 trials), "Apnea" (1 trials) and "Apnea+Hypopnea" (1 trials). Many other conditions were trialed in "Epic Medical Research" in a lesser frequency.

Most popular intervention types in "Epic Medical Research" are "Drug" (13 trials), "Other" (3 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Guselkumab" (3 trials), "PF-07321332" (3 trials), "Ritonavir" (3 trials) and "AXA1125" (1 trials). Other intervention names were less common.

The vast majority of trials in "Epic Medical Research" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Epic Medical Research". undefined are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Epic Medical Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Epic Medical Research, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".